title: Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model.
abstract: Diet and lifestyle produce major effects on tumour incidence, prevalence, and natural history. Moderate dietary restriction has long been recognised as a natural therapy that improves health, promotes longevity, and reduces both the incidence and growth of many tumour types. Dietary restriction differs from fasting or starvation by reducing total food and caloric intake without causing nutritional deficiencies. No prior studies have evaluated the responsiveness of malignant brain cancer to dietary restriction. We found that a moderate dietary restriction of 30-40% significantly inhibited the intracerebral growth of the CT-2A syngeneic malignant mouse astrocytoma by almost 80%. The total dietary intake for the ad libitum control group (n=9) and the dietary restriction experimental group (n=10) was about 20 and 13 Kcal x day(-1), respectively. Overall health and vitality was better in the dietary restriction-fed mice than in the ad libitum-fed mice. Tumour microvessel density (Factor VIII immunostaining) was two-fold less in the dietary restriction mice than in the ad libitum mice, whereas the tumour apoptotic index (TUNEL assay) was three-fold greater in the dietary restriction mice than in the ad libitum mice. CT-2A tumour cell-induced vascularity was also less in the dietary restriction mice than in the ad libitum mice in the in vivo Matrigel plug assay. These findings indicate that dietary restriction inhibited CT-2A growth by reducing angiogenesis and by enhancing apoptosis. Dietary restriction may shift the tumour microenvironment from a proangiogenic to an antiangiogenic state through multiple effects on the tumour cells and the tumour-associated host cells. Our data suggest that moderate dietary restriction may be an effective antiangiogenic therapy for recurrent malignant brain cancers.
authors.affiliation: Biology Department, Boston College, Chestnut Hill, Massachusetts, MA 02467, USA.
authors.forename: P
authors.initials: P
authors.lastname: Mukherjee
authors.forename: M M
authors.initials: MM
authors.lastname: El-Abbadi
authors.forename: J L
authors.initials: JL
authors.lastname: Kasperzyk
authors.forename: M K
authors.initials: MK
authors.lastname: Ranes
authors.forename: T N
authors.initials: TN
authors.lastname: Seyfried
mesh_terms: D000818:Animals; D017209:Apoptosis; D001254:Astrocytoma / Q000098:blood supply / Q000139:chemically induced / Q000473:pathology / Q000628:therapy*; D001932:Brain Neoplasms / Q000098:blood supply / Q000139:chemically induced / Q000473:pathology / Q000628:therapy*; D002455:Cell Division; D003094:Collagen; D004338:Drug Combinations; D005169:Factor VIII / Q000032:analysis; D005508:Food Deprivation; D007797:Laminin; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D016513:Mice, SCID; D009361:Neoplasm Invasiveness; D009363:Neoplasm Proteins / Q000032:analysis; D009368:Neoplasm Transplantation; D009389:Neovascularization, Pathologic / Q000628:therapy*; D011509:Proteoglycans; D014185:Transplantation, Isogeneic; D014407:Tumor Cells, Cultured / Q000473:pathology
chemical_list: D004338:Drug Combinations; D007797:Laminin; D009363:Neoplasm Proteins; D011509:Proteoglycans; C059485:matrigel; D005169:Factor VIII; D003094:Collagen